West Branch Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.21K Buy
105
+1
+1% +$81 ﹤0.01% 248
2026
Q1
$9.01K Buy
104
+1
+1% +$96 ﹤0.01% 237
2025
Q4
$9.92K Hold
103
﹤0.01% 263
2025
Q3
$9.76K Buy
103
+1
+1% +$92 ﹤0.01% 283
2025
Q2
$8.87K Buy
102
+1
+1% +$85 ﹤0.01% 282
2025
Q1
$9.06K Buy
101
+1
+1% +$89 ﹤0.01% 292
2024
Q4
$7.99K Buy
+100
New +$8.66K ﹤0.01% 288
2024
Q3
Hold
0
596
2024
Q1
Sell
-26
Closed -$2.13K 434
2023
Q4
$2.13K Sell
26
-89
-77% -$6.78K ﹤0.01% 399
2023
Q3
$9.01K Hold
115
﹤0.01% 282
2023
Q2
$10.1K Sell
115
-25
-18% -$2.15K 0.01% 281
2023
Q1
$11.3K Sell
140
-23
-14% -$1.88K 0.01% 275
2022
Q4
$12.7K Sell
163
-214
-57% -$17.3K 0.01% 265
2022
Q3
$30K Hold
377
0.02% 200
2022
Q2
$34K Buy
377
+173
+85% +$17.5K 0.02% 195
2022
Q1
$23K Sell
204
-259
-56% -$27.4K 0.01% 234
2021
Q4
$48K Sell
463
-140
-23% -$16.2K 0.02% 200
2021
Q3
$76K Sell
603
-26
-4% -$3.37K 0.04% 161
2021
Q2
$78K Buy
+629
New +$79K 0.04% 161
2020
Q1
Sell
-4,095
Closed -$465K 85
2019
Q4
$465K Buy
+4,095
New +$449K 0.32% 64

Other funds holding MDT

West Branch Capital's MDT Position: Q2 2026 in Review

West Branch Capital increased its Medtronic (MDT) stake by 0.96% in Q2 2026, buying an estimated $81 and bringing the position to 105 shares worth $8.21K. The position accounts for ﹤0.01% of the portfolio, ranked #248.

West Branch Capital first reported a position in MDT in Q4 2019 and has held it in 19 quarters since. The position peaked at $465K in Q4 2019. 592 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • West Branch Capital held 105 shares of Medtronic worth $8.21K as of Q2 2026.
  • West Branch Capital bought 1 Medtronic share in Q2 2026, an estimated $81.
  • Medtronic made up ﹤0.01% of West Branch Capital's portfolio in Q2 2026, its #248 holding.
  • West Branch Capital first reported a position in Medtronic in Q4 2019 and has held it in 19 quarters since.
  • West Branch Capital's Medtronic position peaked at $465K in Q4 2019.
  • 592 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on West Branch Capital's 13F filing for Q2 2026, filed 10 Jul 2026.